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General experimental details 
Solvents were purified and dried according to usual techniques prior to use.
[1]
 All other 
reagents were obtained commercially. Purification of the compounds was performed by 
column chromatography using silica gel 60 H (40–63 m particle size, 230–400 mesh. 
Elution was carried out with hexane or EtOAc:hexane mixtures. All new compounds gave 
single spots on TLC plates run in different solvent systems (hexane or EtOAc:hexane). 
Chromatographic spots were detected by exposure to 254 nm UV light, as well as by 
treatment with iodine or with an acid solution of vanillin. 
The melting points are reported uncorrected. IR spectra were recorded as thin films 
held between NaCl cells or as solid dispersions in KBr disks. The wavelength scale was 
calibrated with a 0.05 mm thick polystyrene film, employing the absorption band at 1601 
cm
–1
. The 
1
H NMR spectra were acquired in CDCl3 (H = 7.27 ppm; C = 77.0 ppm), at 200 or 
400 MHz. Chemical shifts are reported in parts per million in the  scale and J-values are 
given in Hertz. Signals are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), 
dd (doublet of doublets), ddd (doublet of doublet of doublets), and m (multiplet). The low 
resolution mass spectra were obtained from a GC-MS instrument. Fragments are described 
with regards to their m/z ratios, in terms of relative intensity (%) of their signals.  
 
Synthesis and characterization 
Synthesis of precursors 
2-Bromo-4,5-dimethoxybenzaldehyde.
[2]
 A stirred solution of 3,4-dimethoxy 
benzaldehyde (3.98 g, 24mmol) in MeOH (40mL) was treated dropwise with Br2 (1.32mL, 
26 mmol) during 30 min., and the system was left to react at room temperature for a further 
period of 1 hour. Then, the solvent was removed under reduced pressure, the solid was fil-
tered and the solid residue was successively washed with cold water and petroleum ether, 
affording the title compound (5.7 g, 98 %), as a yellowish solid. 
1
H NMR (400 MHz, CDCl3) 
δ 10.18 (s, 1H), 7.41 (s, 1H), 7.05 (s, 1H), 3.96 (s, 3H), 3.91 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 190.6, 154.4, 148.8, 126.5, 120.3, 115.4, 110.4, 56.4, 56.1. 
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(E)-4-Chlorocinnamic acid.
[3,4]
 A solution of 4-chlorobenzaldehyde (5.6 g, 40mmol) 
and malonic acid (9.15 g, 88 mmol) in pyridine (18 mL) was treated with piperidine (0.7 mL) 
and stirred under reflux for 5 h. After completion of the reaction, the system was cooled in an 
ice-bath and treated with a cold HCl solution (2 N, 350 mL). The precipitate was filtered and 
dried under vacuum, affording the title compound (7.20 g, 99%), as a white solid, mp. 248–
252ºC (Lit.
[4]
 249–251ºC). 
 
2.3-Dibromo-3-(4-chlorophenyl)propionic acid.
[5]
 A stirred solution of trans-
cinnamic acid (4.55g, 25 mmol) in AcOH (30 mL) was cooled to 0ºC and treated dropwise 
with Br2 (1.52 mL, 30 mmol) during 30 min. Stirring continued for additional 3 h at room 
temperature, when water (250 mL) was admitted into the reaction. Stirring continued for a 
few minutes and then the solids were filtered through a Büchner funnel, successively wash-
ing with water and cold petroleum ether. The title product (8.24 g, 97%) was obtained as a 
beige solid, mp. 193–195ºC (Lit.[5] 194–195ºC).  
 
(Z)-1-Chloro-4-(2-bromovinyl)benzene.
[6]
 A solution of 2,3-dibromo-3-(4-chloro 
phenyl) propionic acid (3.39 g, 10 mmol) in DMF (20 mL) was treated with Et3N (1.46 
mL, 10.5 mmol) under microwave irradiation (1 min., 500 W). The system was cooled to 
room temperature and the products were extracted with EtOAc (3 × 100 mL). The organic 
phase was washed with water and brine, and dried over anhydrous MgSO4. The solvent 
was removed under reduced pressure and the residue purified by chromatography on silica 
gel, eluting with hexane, furnishing the title product (2.05 g, 95%), as a colorless oil, 
slightly contaminated with the cis isomer. MS (m/z, rel. int., %) 220 ([M+4]
+
, 19), 218 
([M+2]
+
, 74), 137 (M
+
, 100), 102 (77), 75 (51). 
 
1-Chloro-4-ethynylbenzene.
[4]
 18-Crown-6 (300 mg) was added to a stirred solution 
of (Z)-1-chloro-4-(2-bromovinyl)benzene (2.15 g, 10 mmol) in cyclopentane (30 mL). The 
solution was cooled to 0ºC and treated portion wise with 
t
BuOK (1.34 g, 12 mmol), stirring 
at this temperature for additional 30 minutes. Then, the system was further stirred for 30 min. 
at room temperature and 1 h at 40ºC. After completion of the reaction, the system was 
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brought to room temperature and the reaction passed through a chromatographic column, 
eluting with petroleum ether. The product (1.26 g, 93%) was obtained as a white solid, mp. 
45–45.5ºC (Lit.[4] 45–46ºC). 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.6, 2H), 7.29 (d, J = 
8.6, 2H), 3.10 (s, 3H). 
 
Synthesis of the 2(2-aryl-/2-alkyl- ethynyl)benzaldehydes 
Pd(PPh3)2Cl2 (2 mol%), CuI (1 mol%) and the appropriate acetylene (12 mmol) were 
successively added to a stirred mixture of Et3N (30 mL) and the corresponding 2-
bromobenzaldehyde (10 mmol), under argon. The resulting mixture was heated at 50 °C for 
2–5 h. After the reaction was completed, it was extracted with EtOAc (3 × 100 mL). The 
combined extracts were successively washed with water and brine, dried over MgSO4 and 
filtered. The solvent was evaporated under reduced pressure and the residue was purified via 
column chromatography on silica gel, eluting with EtOAc:hexane (2:98). 
 
2-(Phenylethynyl)benzaldehyde (3a).
[7]
 Yellow oil.
1
H NMR (400 MHz, CDCl3) δ 
10.64 (s, 1H), 7.93 (dd, J = 0.82, 7.79 1H), 7.62 (dd, J = 0.7 and 7.7, 1H), 7.57–753 (m, 3H), 
7.42 (t, J = 7.4, 1H), 7.38–7.35 (m, 3H). 13C NMR (100 MHz, CDCl3) δ191.5, 135.8, 133.6, 
133.1, 131.6, 128.9, 128.5, 128.4, 127.2, 126.7, 122.2, 96.2, 84.8.MS (m/z, rel. int., %) 206 
(M
+
, 100), 178 (42), 176 (41), 152 (32), 111 (2), 101 (4), 88 (22), 77 (9). 
 
2-(p-Tolylethynyl)benzaldehyde(3b).
[8]
 Yellow solid. Mp. 46–47ºC (Lit.[8b] 48ºC). 1H 
NMR (200 MHz, CDCl3) δ 10.65 (s, 1H), 7.94 (d, J = 7.8, 1H), 7.65–7.53 (m, 2H), 7.47–
7.40 (m, 3H), 7.25–7.17 (m, 2H), 2.38 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 191.6, 139.3, 
135.9, 133.6, 133.1, 131.6, 129.2, 128.3, 127.2, 127.1, 119.3, 96.6, 84.3, 21.5. MS (m/z, rel. 
int., %) 220 (M
+
, 100), 191 (52), 165 (18), 94 (13), 88 (3), 77 (2). 
 
2-(m-Tolylethynyl)benzaldehyde (3c).
[9]
 Yellow oil. 
1
H NMR (200 MHz, CDCl3) δ 
10.60 (s, 1H), 7.92 (d, J = 7.8, 1H), 7.60 (d, J = 7.7, 1H), 7.54 (td, J = 1.3 and 7.3, 1H), 7.41 
(t, J = 7.3, 1H), 7.37 – 7.34 (m, 2H), 7.26 – 7.22 (m, 1H), 7.18–7.16 (m, 1H), 2.34 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 191.6, 138.2, 135.8, 133.7, 133.1, 132.2, 129.9, 128.7, 128.4, 
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128.3, 127.2, 126.9, 122.1, 96.5, 84.5, 21.1. 
 
2-((4-Chlorophenyl)ethynyl)benzaldehyde (3d).
[8a,10] 
Beige solid. Mp. 91–93ºC 
(Lit.
[10]
 83–89ºC). 1H NMR (200 MHz, CDCl3) δ 10.61 (s, 1H), 7.94 (d, J = 7.6, 1H), 7.64–
7.56 (m, 2H), 7.50–7.44 (m, 3H), 7.36 (d, J = 8.4 2H). 13C NMR (50 MHz, CDCl3) δ 191.4, 
135.8, 135.1, 133.7, 133.2, 132.8, 129.0, 128.8, 127.4, 126.3, 120.8, 95.0, 85.8. MS (m/z, rel. 
int., %) 242 ([M+2]
+
, 31), 240 (94), 205 (100), 177 (53), 176 (81), 88(34). 
 
2-((2-Chlorophenyl)ethynyl)benzaldehyde (3e).
[11]
 Yellowish solid, mp. 64–65ºC 
(Lit.
[11]
 65–67ºC). 1H NMR (400 MHz, CDCl3) δ 10.72 (s, 1H), 7.98–7.85 (m, 1H), 7.69–
7.67 (m, 1H), 7.61–7.57 (m, 2H), 7.49–7.44 (m, 2H), 7.33–7.25 (m, 2H).13C NMR (50 MHz, 
CDCl3) δ 191.8, 136.2, 136.0, 133.7, 133.3, 130.0, 129.4, 128.9, 127.1, 126.6, 126.4, 122.4, 
92.9, 89.9. MS (m/z, rel. int., %) 242 ([M+2]
+
, 4), 240 (12), 205 (100), 88 (78). 
 
5-Fluoro-2-(phenylethynyl)benzaldehyde (3f).
[12]
 Pale yellow solid. Mp. 53–54ºC 
(Lit.
[12b]
 51–52ºC). 1H NMR (200 MHz, CDCl3) δ 10.59 (d, J = 3.2, 1H), 7.67–7.53 (m, 4H), 
7.40–7.34 (m, 3H), 7.33–7.25 (m, 1H). 13C NMR (50 MHz, CDCl3) δ 190.4, 162.3 (d, J = 
252.7), 137.7 (d, J = 6.8), 135.2 (d, J = 7.6), 131.6, 129.1, 128.5, 122.9 (d, J = 3.3), 122.0, 
121.3 (d, J = 22.7), 113.6 (d, J = 23.0), 95.9, 83.7. 
 
5-Methoxy-2-(phenylethynyl)benzaldehyde (3g).
[13]
 Yellow solid. Mp. 80–83ºC 
(Lit.
[13]
 79–81ºC). 1H NMR (200 MHz, CDCl3) δ 10.60 (s, 1H); 7.56–7.52 (m, 3H), 7.42 (d, J 
= 2.7, 1H), 7.37–7.35 (m, 3H), 7.13 (dd, J = 2.8 and 8.5, 1H), 3.86 (s, 3H). 13C NMR (50 
MHz, CDCl3) δ 191.5, 159.7, 137.2, 134.5, 131.4, 128.7, 128.4, 122.6, 121.6, 119.5, 109.8, 
94.8, 84.8, 55.5. 
 
4,5-Dimethoxy-2-(phenylethynyl)benzaldehyde (3h).
[12,14] 
Deep yellow solid. Mp. 
139–143ºC (Lit.[14] 138–140ºC). 1H NMR (200 MHz, CDCl3) δ 10.50 (s, 1H), 7.58–7.53 (m, 
2H), 7.43–7.37 (m, 3H), 7.26 (s, 1H), 7.06 (s, 1H), 4.00 (s, 3H), 3.96 (s, 3H).13C NMR (100 
MHz, CDCl3) δ 190.4, 153.7, 149.8, 131.5, 130.2, 128.8, 128.5, 122.5, 121.5, 114.3, 108.3, 
94.9, 84.8, 56.3, 56.1. MS (m/z, rel. int., %) 266 (M
+
, 87), 251 (56), 195 (79), 165 (61), 152 
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(100), 126 (28), 102 (37), 77 (23), 63 (33). 
 
2-(hex-1-yn-1-yl)benzaldehyde (3i).
[12] 
Yellow oil. 
1
H NMR (200 MHz, CDCl3) δ 
10.54 (s, 1H), 7.88 (d, J = 7.5, 1H), 7.52–7.49 (m, 2H), 7.44–7.33 (m, 1H), 2.49 (t, J = 6.8, 
2H), 1.72–1.40 (m, 4H), 0.96 (t, J = 7.0, 3H). 13C NMR (50 MHz, CDCl3) δ 192.2, 135.9, 
133.6, 133.2, 127.9, 127.7, 126.8, 98.1, 30.5, 22.0, 19.2, 13.5. MS (m/z, rel. int., %) 186 (M
+
, 
6), 157 (22), 144 (97), 128 (35), 115 (100), 102, (11), 89 (22), 77 (9), 63 (18). 
 
Synthesis of the 1,2,3,4-tetrasubstituted pyrroles
[15] 
Benzylamine (10 mmol) and ethyl acetoacetate (10 mmol), were successively added to 
a mixture of NiCl2.6H2O (10 mol%) in MeNO2 (10 mL), magnetically stirred at room tem-
perature. After ~10 minutes, formation of a precipitate was observed and the corresponding 
aldehyde (10 mmol) was added. The open system was heated at 80ºC for 6–12 h. After the 
reaction was completed, the system was cooled to room temperature and the products were 
extracted with EtOAc (3 × 100 mL), the organic phase was washed with water and brine, and 
dried over anhydrous MgSO4 and filtered. The solvent was evaporated under reduced pres-
sure and the residue was purified via column chromatography on silica gel, eluting with 
EtOAc:hexane (5:95). 
 
Ethyl 1-benzyl-2-methyl-4-(2-(phenylethynyl)phenyl)-1H-pyrrole-3-carboxylate 
(2a). Yelow oil. Yield: 47%. 
1
H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 1.2 and 7.3, 1H), 
7.35–7.30 (m, 3H), 7.26 (dd, J = 1.2 and 7.2, 1H), 7.23–7.19 (m, 4H), 7.18–7.13 (m, 3H), 
6.96 – 6.94 (m, 2H), 6.57 (s, 1H), 4.95 (s, 2H), 4.05 (q, J = 7.1, 2H), 2.45 (s, 3H), 0.97 (t, J = 
7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 165.6, 138.7, 136.8, 135.5, 131.6, 131.3, 129.7, 
128.6, 128.0, 127.6, 127.5, 127.4, 126.1, 126.0, 124.1, 123.5, 123.2, 120.7, 112.3, 91.2, 89.8, 
59.1, 50.2, 13.6, 11,0. IR (film, ) 3401, 3060, 3029, 2978, 2900, 2215, 1693 cm–1. MS (m/z, 
rel. int., %) 419 (M
+
, 21), 346 (18), 254 (10), 228 (3), 226 (6), 91 (100), 77 (2), 65 (14). 
HRMS (ESI, m/z) calcd. for C25H29NO2 ([M+H]
+
): 420.1964; Found: 420.1933. 
 
Ethyl 1-benzyl-2-methyl-4-(2-(p-tolylethynyl)phenyl)-1H-pyrrole-3-carboxylate 
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(2b). White solid. Mp. 119–120ºC. Yield: 41%. 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 
7.3, 1H), 7.32–7.31 (m, 1H), 7.28–7.21 (m, 7H), 7.05 (d, J = 7.9, 2H), 7.03–7.01 (m, 2H), 
6.64 (s, 1H), 5.06 (s, 2H), 4.06 (q, J = 7.1, 2H), 2.48 (s, 3H), 2.32 (s, 3H), 0.98 (t, J = 7.1, 
3H). 
13
C NMR (100 MHz, CDCl3) δ 165.8, 138.7, 137.8, 136.9, 135.7, 131.7, 131.4, 129.8, 
128.9, 128.8, 127.6, 127.4, 126.3, 126.1, 124.3, 123.5, 120.8, 120.6, 112.4, 91.5, 89.1, 59.3, 
50.4, 21.4, 13.8, 11.2. IR (KBr, ) 3403, 3085–3028, 2978, 2868, 2213, 1694 cm–1. MS (m/z, 
rel. int., %) 433 (M
+
, 35), 258 (42), 268 (19), 225 (12), 105 (5), 91 (100), 65 (13). Anal. 
Calc. for C30H27NO2C, 83.11; H, 6.28; N, 3.23. Found C, 83.41; H, 6.40; N, 3.24. 
 
Ethyl 1-benzyl-2-methyl-4-(2-(m-tolylethynyl)phenyl)-1H-pyrrole-3-carboxylate 
(2c). Pale yellow solid. Mp. 136–138ºC. Yield: 40%. 1H NMR (400 MHz, CDCl3) δ 7.52 
(dd, J = 1.3 and 7.5, 1H), 7.31–7.31 (dd, J = 1.3 and 7.4, 1H), 7.27–7.18 (m, 3H), 7.16–7.13 
(m, 4H), 7.13–7.09 (m, 1H), 7.04–7.02 (m, 1H), 6.98–6.96 (m, 2H), 6.59 (s, 1H), 4.98 (s, 
2H), 4.05 (q, J = 7.1, 2H), 2.46 (s, 3H), 2.23 (s, 3H), 0.97 (t, J = 7.1, 3H). 
13
C NMR (100 
MHz, CDCl3) δ 165.5, 138.8, 137.5, 136.8, 135.5, 132.0, 131.5, 129.7, 128.6, 128.5, 128.4, 
127.9, 127.4, 126.1, 126.0, 124.2, 123.4, 120.8, 112.4, 91.5, 89.4, 59.1, 50.2, 21.0, 13.6, 
11.0. IR (KBr, ) 3425, 3055, 3032, 2978, 2924, 2206 cm–1. MS (m/z, rel. int., %) 433 (M+, 
48), 360 (50), 356 (45), 268 (20), 91 (100), 65 (11). HRMS (ESI, m/z) calcd. for C30H27NO2 
([M+H]
+
): 434.2120; Found: 434.2118. 
 
Ethyl 1-benzyl-4-(2-((4-chlorophenyl)ethynyl)phenyl)-2-methyl-1H-pyrrole-3-
carboxylate (2d). Yellow oil. Yield: 40%. 
1
H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 7.5, 
1H), 7.31 (d, 7.5, 1H), 7.27–7.21 (m, 4H), 7.19–7.15 (m, 5H), 6.97–6.95 (m, 2H), 6.57 (s, 
1H), 4.95 (s, 2H), 4.04 (q, J = 7.1, 2H), 2.45 (s, 3H), 0.96 (t, J = 7.1, 3H). 
13
C NMR (100 
MHz, CDCl3) δ 165.4, 138.8, 136.7, 135.4, 133.5, 132.4, 131.4, 129.6, 128.5, 128.2, 127.6, 
127.4, 126.1, 125.9, 124.0, 122.8, 122.0, 120.6, 112.3, 90.8, 90.0, 59.0, 50.1, 13.5, 10.9. 
IR(film, ) 3425, 3062, 3031, 2978, 2893, 2214, 1689 cm–1. HRMS (ESI, m/z) calcd. for 
C29H24ClNO2 ([M+Na]
+
): 476.1393; Found: 476.1382. 
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Ethyl 1-benzyl-4-(2-((2-chlorophenyl)ethynyl)phenyl)-2-methyl-1H-pyrrole-3-
carboxylate (2e). Yellow oil. Yield: 38%. 
1
H NMR (400 MHz, CDCl3) δ 7.60–7.58 (m, 1H), 
7.37–7.29 (m, 4H), 7.28–7.22 (m, 2H), 7.21–7.18 (m, 2H), 7.17–7.10 (m, 2H), 7.04–7.01 (m, 
2H), 6.68 (s, 1H), 5.05 (s, 2H), 4.05 (q, J = 7.1, 2H), 2.47 (s, 3H), 0.99 (t, J = 7.1, 3H). 
13
C 
NMR (100 MHz, CDCl3) δ 165.6, 139.0, 136.9, 135.8, 135.6, 133.3, 132.0, 130.1, 129.0, 
128.7, 128.6, 127.8, 127.5, 126.3, 126.2, 126.1, 124.1, 123.7, 123.1, 121.0, 112.4, 95.0, 88.0, 
59.1, 50.4, 13.7, 11.2. IR (film, ) 3371, 3063, 3024, 2978, 2924, 2214, 1689 cm–1. HRMS 
(ESI, m/z) calcd. for C29H24ClNO2([M+Na]
+
): 476.1393; Found: 476.1388. 
 
Ethyl 1-benzyl-4-(5-fluoro-2-(phenylethynyl)phenyl)-2-methyl-1H-pyrrole-3-
carboxylate (2f). Yellow oil. Yield: 35%. 
1
H NMR (400 MHz, CDCl3) δ 7.51–7.47 (m, 1H), 
7.34–7.31 (m, 2H), 7.25–7.22 (m, 3H), 7.21–7.18 (m, 3H), 7.06–7.03 (m, 1H), 7.01–6.99 (m, 
2H), 6.93 (td, J= 2.7 and 8.4, 1H), 6.65 (s, 1H), 5.04 (s, 2H), 4.08 (q, J = 7.1, 2H), 2.48 (s, 
3H), 1.02 (t, J = 7.1, 3H). IR (film, ) 3396, 3064, 3032, 2977, 2850, 2217, 1701 cm–1. MS 
(m/z, rel. int., %) 437 (M
+
, 39), 364 (29), 360 (28), 91 (100), 65 (11). 
13
C NMR (100 MHz, 
CDCl3) δ 165.4, 161.8 (d, J = 248.5), 141.1 (d, J = 8.9), 136.6, 135.9, 133.2 (d, J = 8.6), 
131.3, 128.8, 128.1, 127.7, 127.6, 126.2, 123.5, 123.2 (d, J = 1.9), 121.0, 119.5 (d, J = 3.0), 
116.9 (d, J = 22.0), 113.1 (d, J = 21.8), 112.2, 90.9, 88.8, 59.3, 50.4, 13.7, 11.1. Anal. Calcd. 
for C29H24FNO2 C, 79.61; H, 5.53; N, 3.20. Found C, 79.19; H, 5.59; N, 3.11. 
 
Ethyl 1-benzyl-4-(5-methoxy-2-(phenylethynyl)phenyl)-2-methyl-1H-pyrrole-3-
carboxylate (2g). Yellow oil. Yield: 32%.
1
H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.5, 
1H), 7.33–7.30 (m, 2H), 7.22–7.15 (m, 6H), 7.00–6.97 (m, 2H), 6.88 (d, J = 2.6, 1H), 6.77 
(dd, J = 2.7 and 8.5, 1H), 6.61 (s, 1H), 4.99 (s, 2H), 4.07 (q, J = 7.1, 2H), 3.76 (s, 3H), 2.46 
(s, 3H), 1.00 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 165.5, 158.9, 140.4, 136.8, 
135.5, 132.9, 131.2, 128.6, 127.9, 127.4, 127.2, 126.2, 124.1, 124.0, 120.8, 115.8, 115.4, 
112.4, 111.9, 90.0, 89.9, 59.1, 55.1, 50.3, 13.7, 11.0. IR (film, ) 3379, 3062, 3032, 2978, 
2931, 2214, 1697 cm
–1
. MS (m/z, rel. int., %) 449 (M
+
, 59), 376 (54), 284 (11), 91 (100), 77 
(2). Anal. Calcd. for C30H27NO3 C, 80.15; H, 6.05; N, 3.12. Found C, 79.39; H, 6.37; N, 
3.20. 
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Ethyl 1-benzyl-4-(4,5-dimethoxy-2-(phenylethynyl)phenyl)-2-methyl-1H-pyrrole-
3-carboxylate (2h). Yellow oil. Yield: 42%. 
1
H NMR (400 MHz, CDCl3) δ 7.34–7.32 (m, 
2H), 7.25–7.22 (m, 6H), 7.05–7.03 (m, 3H), 6.86 (s, 1H), 6.67 (s, 1H), 5.07 (s, 2H), 4.09 (q, 
J = 7.1, 2H), 3.91 (s, 3H), 3.88 (s, 3H), 2.49 (s, 3H), 1.05 (t, J = 7.1, 3H). 
13
C NMR (100 
MHz, CDCl3) δ 165.7, 148.7, 147.3, 136.9, 135.6, 132.4, 131.3, 128.8, 128.1, 127.6, 127.5, 
126.3, 124.1, 123.9, 120.9, 115.2, 114.5, 113.5, 112.5, 90.0, 89.9, 59.2, 56.0, 55.8, 50.5, 
13.9, 11.2. IR (film, ) 3462, 3062, 3029, 2993, 2835, 2203, 1686 cm–1. MS (m/z, rel. int., 
%) 479 (M
+
, 51), 407 (19), 406 (56), 402 (19), 249 (9), 189 (3), 91 (100), 77 (2). Anal. 
Calcd. for C31H29NO4 C, 77.64; H, 6.10; N, 2.92. Found C, 77.61; H, 6.03; N, 2.65. 
 
Ethyl 1-benzyl-4-(2-(hex-1-in-1-yl)phenyl)-2-methyl-1H-pyrrole-3-carboxylate 
(2i). Yellow oil. Yield: 40%. 
1
H NMR (200 MHz, CDCl3) δ 7.42–7.37 (m, 1H), 7.31–7.22 
(m, 4H), 7.20–7.10 (m, 2H), 7.06–7.02 (m, 2H), 6.58 (s, 1H), 5.02 (s, 2H), 4.05 (q, J = 7.1, 
2H), 2.44 (s, 3H), 2.26 (t, J = 6.7, 2H), 1.50–1.21 (m, 4H), 0.99 (t, J = 7.1, 3H), 0.83 (t, J = 
6.9, 3H). 
13
C NMR (50 MHz, CDCl3) δ 165.6, 138.4, 136.9, 135.3, 131.6, 129.5, 128.6, 
127.5, 126.6, 126.2, 125.8, 124.3, 124.0, 120.5, 112.3, 92.1, 80.4, 59.0, 50.2, 30.5, 21.6, 
19.0, 13.6, 13.5, 10.9. IR (film, ) 3395, 3062, 3029, 2228, 1702 cm–1. MS (m/z, rel. int., %) 
399 (M
+
, 23), 326 (18), 284 (12), 235 (4), 91 (100), 65 (10), 55 (1). HRMS (ESI, m/z) calcd. 
for C27H29NO2 ([M+Na]
+
): 422.2096; Found: 476.2101. 
 
Ethyl 1-benzyl-4-(2-((4-fluorophenyl)ethynyl)phenyl)-2-methyl-1H-pyrrole-3-
carboxylate (2j). Yellow oil; Yield: 31%. 
1
H NMR (400 MHz, CDCl3) δ 7.51 (d, 7.4, 1H), 
7.33-7.17 (m, 8H), 7.01-6.99 (m, 2H), 6.92 (t, 8.5, 2H), 6,61 (s, 1H), 5.03 (s, 2H), 4.05 (q, 
7.2, 2H), 2.48 (s, 3H), 0,98 (t, 7.2, 3H). 
13
C NMR (100 MHz, CDCl3) δ 165.7, 162.2 (d, 
248.9), 138.8, 136.9, 135.6, 133.3 (d, 8.1), 131.5, 129.8, 128.7, 127.7, 127.6, 126.3, 126.1, 
124.3, 123.2, 120.7, 119.83 (d, 3.3), 115.32 (d, 22.0), 112.5, 90.2, 89.5, 59.2, 50.41, 13.7, 
11.1. MS (m/z, rel. int., %): 437 (M
+
, 15), 364 (17), 360 (4), 272 (8), 91 (100), 65 (20). 
HRMS (ESI, m/z) calcd. for C29H24FNO2 ([M+Na]
+
): 460.1689; Found: 460.1723. 
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Ethyl 2-methyl-1-phenethyl-4-(2-(phenylethynyl)phenyl)-1H-pyrrole-3-
carboxylate (2k). Yellow oil. Yield: 45%. 
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 7.2, 
1H), 7.41–7.38 (m, 2H), 7.27–7.25 (m, 3H), 7.24–7.22 (m, 2H), 7.21–7.18 (m, 1H), 7.17–
7.14 (m, 3H), 6.98 (dd, J = 2.4 and 7.2, 2H), 6.45 (s, 1H), 4.04 (q, J = 7.1, 2H), 3.99 (t, J = 
6.8, 2H), 2.93 (t, J = 6.8, 2H), 2.35 (s, 3H), 0.96 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, 
CDCl3) δ 165.7, 138.9, 137.6, 135.3, 131.7, 131.5, 129.5, 128.7, 128.5, 128.1, 127.7, 127.6, 
126.7, 126.0, 124.1, 123.7, 123.4, 119.7, 111.7, 91.1, 89.9, 59.1, 48.1, 37.5, 13.7, 10.8. 
IR(film, ) 3410, 3055, 3024, 2978, 2931, 2214, 1698 cm–1. MS (m/z, rel. int., %) 433 (M+, 
100), 360 (44), 328 (41), 268 (39), 253 (63), 180 (10), 105 (81), 91 (44), 77 (43). HRMS 
(ESI, m/z) calcd. for C30H27NO2 ([M+H]
+
): 434.2120; Found: 434.2118. 
 
1-Benzyl-2-methyl-4-(2-(phenylethynyl)phenyl)-1H-pyrrole (2l). An alcoholic solu-
tion of NaOH (4 % P/V, 40 mL) was added to a stirred solution of compound 2a (4.195 g, 
10.0 mmol) in EtOH (40 mL) and the mixture was heated under reflux for 5 h. The system 
was cooled in an ice bath and the solution was adjusted to pH 5 with glacial acetic acid. The 
thus formed precipitate was collected by filtration, affording 1-benzyl-2-methyl-4-(2-
(phenylethynyl)phenyl)-1H-pyrrole carboxylic acid (3.408 g, 87%), as a beige solid, mp. 
204–204.5ºC. MS (m/z, rel. int., %) 391 (M+, 2), 242 (20), 189(8), 111(14), 97(29), 83(31), 
57(85), 43(100). IR (KBr, ) 3432, 3132, 3095, 3027, 2963, 2851, 2215, 1655 cm–1. HRMS 
(ESI, m/z) calcd. for C27H21NO2 ([M+Na]
+
): 414.1470; Found: 414.1467. 
To a stirred solution of the above acid (391 mg, 1.0 mmol) in quinoline (2 mL) was 
added metallic Cu (0.7 mmol) and the system was heated under reflux for 4 hours. Then, it 
was cooled with an ice bath and the pH of the solution was adjusted to 4 with 2N HCl. The 
products were extracted with EtOAc (3 × 10 mL), the organic phase was washed with water, 
brine and saturated NaHCO3 solution, dried over MgSO4 and filtered. The solvent was evap-
orated under reduced pressure and the residue was purified via column chromatography on 
silica gel, eluting with EtOAc:hexane (5:95), affording compound 2k (236 mg, 68%), as a 
yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 8.25–8.22 (m, 1H), 7.82–7.79 (m, 1H), 7.51 (ddd, 
J = 1.3, 6.9 and 8.2, 1H), 7.51 (ddd, J = 1.3, 6.9 and 8.2, 1H), 7.26–7.24 (m, 2H), 7.19–7.14 
(m, 4H), 7.10–7.06 (m, 3H), 6.99 (s, 1H), 6,37 – 6,34 (m, 2H), 4.95 (s, 2H), 2.35 (s, 3H). 
HRMS (ESI, m/z) calcd. for C26H21N ([M+H]
+
): 348.1752; Found: 348.1752. 
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Synthesis of the 3H-benzo[e]indoles 
Solid K2CO3 (0.5 mmol) was added to a solution of the pyrrole (0.25 mmol) in CH2Cl2 
(2 mL) and the system was stirred at room temperature for 10 minutes. Then, it was treated 
dropwise with a solution of iodine (0.3 mmol) in CH2Cl2 (2 mL). After the reaction was 
completed, the product was extracted with CH2Cl2 (3 × 50 mL). The combined organic ex-
tracts were successively washed with 15% aqueous Na2S2O3 (50 mL), water and brine, dried 
over MgSO4 and filtered. The solvent was evaporated under reduced pressure and the residue 
was purified via column chromatography on silica gel eluting with EtOAc:hexane (10:90). 
 
Ethyl 3-benzyl-5-iodo-2-methyl-4-phenyl-3H-benzo[e]indole-1-carboxylate (1a). 
White solid. Mp. 152–153ºC. Yield: 93%. 1H NMR (400 MHz, CDCl3) δ 8.79–8.76 (m, 1H), 
8.44–8.41 (m, 1H), 7.57 (ddd, J = 1.4, 6.8 and 8.2, 1H), 7.51 (ddd, J = 1.4, 6.8 and 8.3, 1H), 
7.39–7.33 (m, 1H), 7.24–7.19 (m, 2H), 7.14–7.09 (m, 3H), 6.94 (dd, J = 1.3 and 8.2, 2H), 
6.34 (dd, J = 1.9 and 7.5, 2H), 4.73 (s, 2H), 4.53 (q, J = 7.1, 2H), 2.46 (s, 3H), 1.47 (t, J = 
7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.5,143.8, 141.4, 137.3, 134.3, 133.3, 131.6, 
130.7, 130.1, 128.4, 128.2, 128.1, 127.3, 127.0, 126.1, 125.7, 125.3, 124.9, 122.0, 109.1, 
104.3,60.7, 48.2, 14.4, 12.0. IR (KBr, ) 3363, 3055, 3026, 2978, 2908, 1697 cm–1. MS (m/z, 
rel. int., %) 545 (M
+
, 2), 418 (65), 373 (6), 281 (19), 253 (26), 105 (5), 91 (100), 77 (2), 45 
(6). Anal. Calcd. for C29H24INO2 C, 63.86; H, 4.44; N, 2.57. Found C, 64.18; H, 4.61; N, 
2.35. 
 
Ethyl 3-benzyl-5-iodo-2-methyl-4-(p-tolyl)-3H-benzo[e]indole-1-carboxylate (1b). 
White solid. Mp. 147–148ºC. Yield: 96%. 1H NMR (400 MHz, CDCl3) δ 8.77 (dd, J = 0.9 
and 8.2, 1H), 8.42 (dd, J = 0.9 and 8.3, 1H), 7.56 (ddd, J = 1.4, 6.8 and 8.3, 1H), 7.51, (ddd, 
J = 1.4, 6.8 and 8.2, 1H), 7.14–7.09 (m, 3H), 7.01 (d, J = 7.7, 2H), 6.82 (d, J = 7.9, 2H), 
6.36–6.34 (m, 2H), 4.75 (s, 2H), 4.52 (q, J = 7.1, 2H), 2.45 (s, 3H), 2.38 (s, 3H), 1.46 (t, J = 
7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.4, 141.3, 140.7, 138.0, 137.4, 134.2, 133.4, 
131.8, 130.6, 129.8, 128.7, 128.2, 127.2, 126.9, 126.0, 125.6, 125.2, 124.8, 121.8, 108.9, 
104.6, 60.6, 48.1, 21.4, 14.3, 12.0. IR (KBr, ) 3369, 3061, 3028, 2970, 2920, 1703 cm–1. 
MS (m/z, rel. int., %) 559 (M
+
, 100), 487 (2), 432 (1), 386 (12), 268 (15), 91 (57), 65 (7). 
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Anal. Calcd. for C30H26INO2 C, 64.41; H, 4.68; N, 2.50. Found C, 64.37; H, 4.76; N, 2.39. 
 
Ethyl 3-benzyl-5-iodo-2-methyl-4-(m-tolyl)-3H-benzo[e]indole-1-carboxylate (1c). 
Yellow solid. Mp. 136–138ºC. Yield: 94%. 1H NMR (400 MHz, CDCl3) δ 8.77 (dd, J = 0.9 
and 8.3, 1H), 8.42 (dd, J = 0.9 and 8.3, 1H), 7.57 (ddd, J = 1.4, 6.9 and 8.3, 1H), 7.51 (ddd, J 
= 1.3, 6.9 and 8.1, 1H), 7.20–7.13 (m, 5H), 6.84 (d, J = 6.5, 1H), 6.63 (s, 1H), 6.36 (dd, J = 
2.8 and 6.4, 2H), 4.77 (d, J = 17.9, 1H), 4.68 (d, J = 17.9, 1H), 4.53 (q, J = 7.1, 2H), 2.45 (s, 
3H), 2.04 (s, 3H), 1.47 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.4, 143.5, 141.3, 
137.9, 137.5, 134.2, 133.4, 131.6, 130.8, 130.6, 128.8, 128.3, 127.8, 127.2, 127.1, 126.8, 
126.0, 125.6, 125.3, 124.7, 121.8, 108.9, 104.1, 60.7, 48.1, 21.1, 14.3, 12.0. IR (KBr, ) 
3378, 3060, 3030, 2925, 2870, 1707 cm
–1
. MS (m/z, rel.int., %) 559 (M
+
, 33), 386 (5), 341 
(8), 137 (10), 91 (44), 81 (52), 69 (100), 43 (63). HRMS (ESI, m/z) calcd. for C30H26INO2 
([M+Na]
+
): 582.0906; Found: 582.0904. 
 
Ethyl 3-benzyl-4-(4-chlorophenyl)-5-iodo-2-methyl-3H-benzo[e]indole-1-
carboxylate (1d). White solid. Mp. 147–148ºC. Yield: 90%. 1H NMR (400 MHz, CDCl3) δ 
8.78–8.75 (m, 1H), 8.41–8.38 (m, 1H), 7.57 (ddd, J = 1.4, 6.8 and 8.3, 1H), 7.51 (ddd, J = 
1.4, 6.8 and 8.2, 1H), 7.17–7.11 (m, 5H), 6.87–6.84 (m, 2H), 6.38–6.36 (m, 2H), 4.79 (s, 
2H), 4.53 (q, J = 7.1, 2H), 2.47 (s, 3H), 1.47 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 
167.3, 142.1, 141.4, 137.0, 134.3, 132.0, 131.6, 131.4, 130.6, 128.5, 128.2, 127.4, 127.2, 
126.4, 125.9, 125.4, 124.8, 122.2, 109.2, 104.4, 60.8, 48.3, 14.4, 12.0. IR (KBr, ) 3365, 
3108, 3087, 2982, 2873, 1693 cm
–1
. MS (m/z, rel. int., %) 581 ([M+2]
+
, 17), 579 (44), 453 
(10), 253 (8), 149 (21), 91 (100), 69 (22). HRMS (ESI, m/z) calcd. for C29H23ClINO2 
([M+H]
+
): 580.0540; Found: 580.0544. 
 
Ethyl 3-benzyl-4-(2-chlorophenyl)-5-iodo-2-methyl-3H-benzo[e]indole-1-
carboxylate (1e). White solid. Mp. 175–175.5ºC. Yield: 89%. 1H NMR (400 MHz, CDCl3) δ 
8.80 (dd, J = 0.8 and 8.3, 1H), 8.41 (dd, J = 0.8 and 8.4, 1H), 7.58 (ddd, J = 1.3, 6.8 and 8.3, 
1H), 7.51 (ddd, J= 1.3, 6.8 and 8.2, 1H), 7.40 (dd, J= 0.9 and 8.0, 1H), 7.29 (td, J = 1.6 and 
7.7,1H), 7.16–7.07 (m, 3H), 6.92 (td, J = 1.1 and 7.4, 1H), 6.77 (dd, J = 1.5 and 7.6, 1H), 
6.38 (d, J = 6.7, 2H), 4.95 (d, J = 18.0, 1H), 4.76 (d, J = 18.0, 1H), 4.54 (q, J = 7.1, 2H), 
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2.49 (s, 3H), 1.47 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.4, 142.1, 141.3, 136.8, 
134.7, 134.2, 132.3, 131.1, 130.6, 130.4, 129.8, 129.2, 128.3, 127.4, 127.1, 126.5, 126.4, 
125.7, 125.3, 124.8, 122.2, 109.1, 104.3, 60.7, 47.9, 14.4, 12.0. IR (KBr, ) 3379, 3124, 
3024, 2978, 2869, 1697 cm
–1
. MS (m/z, rel.int., %) 581 ([M+2]
 +
, 17), 579 (M
+
, 44), 453 
(10), 253 (8), 149 (21), 91 (100), 69 (22). HRMS (ESI, m/z) calcd. for C29H23ClINO2 
([M+H]
+
): 580.0540; Found: 580.0530. 
 
Ethyl 3-benzyl-8-fluoro-5-iodo-2-methyl-4-phenyl-3H-benzo[e]indole-1-
carboxylate (1f). Yellow solid. Mp. 161–162ºC. Yield: 93%. 1H NMR (400 MHz, CDCl3) δ 
8.62 (dd, J =2.5 and 11.9, 1H), 8.43 (dd, J =5.9 and 9.3, 1H), 7.37–7.33 (m, 1H), 7.25–7.23–
(m, 1H), 7.22–7.18 (m, 2H), 7.14–7.09 (m, 3H), 6.93–6.91 (m, 2H), 6.34–6.32 (m, 2H), 4.73 
(s, 2H), 4.54 (q, J = 7.1, 2H), 2.46 (s, 3H), 1.48 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) 
δ 166.9, 160.9 (d, J = 245.2), 143.5, 142.0, 137.1, 136.8 (d, J = 8.9), 132.6, 131.8, 130.0, 
128.3, 128.2, 128.1, 127.9 (d, J = 10.0), 127.5, 127.0, 124.8, 121.4 (d, J = 4.4), 114.9 (d, J = 
24.2), 109.5 (d, J = 23.8), 108.9, 103.7, 60.8, 48.1, 14.2, 12.1. IR (KBr, ) 3386, 3105, 3027, 
2988, 2869, 1702 cm
–1
. MS (m/z, rel. int., %) 563 (M
+
, 100), 436 (1), 363 (8), 345 (17), 272 
(13), 91 (82). Anal. Calcd. for C29H23FINO2 C, 61.82; H, 4.11; N, 2.49. Found C, 61.67; H, 
4.02; N, 2.41. 
 
3-Benzyl-5-iodo-8-methoxy-2-methyl-4-phenyl-3H-benzo[e]indole-1-carboxylate 
(1g). Yellow solid. Mp. 171–171.5ºC. Yield: 89%. 1H NMR (400 MHz, CDCl3) δ 8.37 (d, J 
= 2.5, 1H), 8.32 (d, J = 9.2, 1H), 7.35–7.32 (m, 1H), 7.21–7.17 (m, 2H), 7.16–7.08 (m, 4H), 
6.95–6.93 (m, 2H), 6.36–6.34 (m, 2H), 4.72 (s, 2H), 4.5 (q, J = 7.1, 2H), 3.99 (s, 3H), 2.44 
(s, 3H), 1.45 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.5, 158.1, 143.9, 141.1, 
137.4, 135.8, 131.9, 130.8, 130.4, 128.3, 128.1, 128.0, 126.9, 125.7, 124.9, 121.4, 116.9, 
109.0, 105.4, 104.0, 60.6, 55.5, 48.1, 14.4, 12.2. IR (KBr, ) 3437, 3138, 3023, 2997, 2898, 
2832, 1690 cm
–1
. MS (m/z, rel. int., %) 575 (M
+
, 100), 530 (4), 448 (2), 357 (52), 241 (16), 
91 (66), 57 (15). Anal. Calcd. for C30H26INO3 C, 62.62; H, 4.55; N, 2.43. Found C, 62.67; H, 
4.58; N, 2.30. 
 
  
S14 
Ethyl 3-benzyl-5-iodo-7,8-dimethoxy-2-methyl-4-phenyl-3H-benzo[e]indole-1-
carboxylate (1h). Yellow solid. Mp. 181–182ºC. Yield: 73%. 1H NMR (400 MHz, CDCl3) δ 
8.55 (s, 1H), 7.82 (s, 1H), 7.35 (t, J = 7.6, 1H), 7.20 (t, J = 7.2, 2H), 7.14–7.10 (m, 3H), 6.94 
(d, J = 7.5, 2H), 6.34 (d, J = 7.6, 2H), 4.72 (s, 2H), 4.50 (q, J = 7.1, 2H), 4.10 (s, 3H), 4.05 
(s, 3H), 2.46 (s, 3H), 1.45 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.5, 149.1, 
148.8, 144.0, 141.7, 137.4, 131.1, 131.0, 130.3, 128.3, 128.1, 128.0, 126.9, 126.2, 124.9, 
122.1, 121.8, 114.3, 108.2, 105.9, 103.0, 60.6, 56.1, 55.8, 48.1, 14.4, 12.4. IR (KBr, ) 3350, 
3150, 3027, 2992, 2902, 2827, 1985, 1738, 1699 cm
–1
. MS (m/z, rel. int., %) 605 (M
+
, 13), 
432 (1), 387 (7), 261 (3), 149 (12), 91 (11), 69 (100), 55 (21), 43 (25). Anal. Calcd. for 
C31H28INO4 C, 61.50; H, 4.66; N, 2.31. Found C, 61.34; H, 4.52; N, 2.27. 
 
Ethyl 3-benzyl-4-butyl-5-iodo-2-methyl-3H-benzo[e]indole-1-carboxylate (1i). 
White solid. Mp. 148–148.5ºC. Yield: 61%. 1H NMR (400 MHz, CDCl3) δ 8.57–8.53 (m, 
1H), 8.42–8.38 (m, 1H), 7.49–7.43 (m, 2H), 7.31–7.23 (m, 3H), 6.85 (d, J = 6.8, 2H), 5.56 
(s, 2H), 4.51 (q, J = 7.1, 2H), 3.15 (t, J = 7.9, 2H), 2.55 (s, 3H), 1.77–1.57 (m, 2H), 1.47–
1.40 (m, 5H), 0.95 (t, J = 7.2, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.6, 140.6, 137.4, 
134.0, 131.8, 131.2, 131.1, 129.1, 127.5, 126.5, 125.4, 125.3, 124.9, 122.1, 109.2, 105.1, 
60.7, 49.0, 38.7, 32.9, 22.6, 14.3, 13.8, 12.0. IR (KBr, ) 3439, 3046, 3024, 2979, 2870, 
1981, 1820, 1690 cm
–1
. MS (m/z, rel. int., %) 525 (M
+
, 41), 480 (2), 398 (2), 352 (17), 283 
(12), 137 (10), 91 (72), 81 (59), 69 (100), 57 (27), 43 (28). Anal. Calcd. for C27H28INO2 C, 
61.72; H, 5.37; N, 2.67. Found C, 61.74; H, 5.32; N, 2.72. 
 
Ethyl 3-benzyl-4-(4-fluorophenyl)-5-iodo-2-methyl-3H-benzo[e]indole-1-carboxy- 
late (1j). White solid. Mp. 154–155ºC. Yield: 65%. 1H NMR (400 MHz, CDCl3) δ 8.77 (dd, 
J = 0.8 and 8.2, 1H), 8.40 (dd, J = 0.9 and 8.4, 1H), 7.49 – 7.59 (m, 2H), 7.14 – 7.10 (m, 
3H), 6.88 – 6.87 (m, 4H), 6.37 – 6.35 (m, 2H), 4.77 (s, 2H), 4.53 (q, J = 7.1, 2H), 2.47 (s, 
3H), 1.46 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.3, 162.5 (d, J = 247.9), 141.3, 
139.6 (d, J = 3.5), 137.0, 134.3, 132.1, 131.8 (d, J = 8.1), 130.6, 128.4, 127.3, 127.1, 126.2, 
125.8, 125.3, 124.7, 122.0, 115.0 (d, J = 21.4), 114.9, 109.1, 104.9, 60.7, 48.1, 14.3, 12.0. 
MS (m/z, rel. int., %): 563 (M
+
, 8), 262 (19), 183 (21), 108 (18), 91 (32), 69 (100), 41 (70). 
HRMS (ESI, m/z) calcd. for C29H23FINO2 ([M+Na]
+
): 586.0655; Found: 586.0663. 
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Ethyl 5-iodo-2-methyl-3-phenylethynyl-4-phenyl-3H-benzo[e]indole-1-carboxylate 
(1k). White solid. Mp. 120–121ºC. Yield: 85%. 1H NMR (400 MHz, CDCl3) δ 8.70–8.67 (m, 
1H), 8.45–8.43 (m, 1H), 7.56–7.48 (m, 5H), 7.40–7.38 (m, 2H), 7.18–7.16 (m, 3H), 6.71–
6.99 (m, 2H), 4.51 (q, J = 7.1, 2H), 3.69 (t, J = 8.1, 2H), 2.56 (t, J = 8.1, 2H), 2.47 (s, 3H), 
1.46 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.5, 144.6, 140.8, 137.4, 134.3, 133.0, 
131.0, 130.6, 130.5, 128.7, 128.6, 128.4, 128.4, 127.1, 126.7, 126.1, 125.7, 125.2, 122.1, 
109.0, 104.4, 60.7, 45.9, 37.0, 14.4, 12.1. IR (KBr, ) 3367, 3053, 3017, 2973, 2923, 1955, 
1803, 1697 cm
–1
. MS (m/z, rel. int., %) 559 (M
+
, 30), 558 (100), 421 (86), 311 (23), 268 
(31), 201 (3), 105 (41), 101 (2), 77 (23), 69 (55), 45 (15), 43 (41). Anal. Calcd. for 
C30H26INO2 C, 64.41; H, 4.68; N, 2.50. Found C, 64.52; H, 4.59; N, 2.38. 
 
3-Benzyl-5-iodo-2-methyl-4-phenyl-3H-benzo[e]indole (1l). White solid. Mp. 171–
172ºC. Yield: 90%. 
1
H NMR (400 MHz, CDCl3) δ 8.36–8.34 (m, 1H), 8.21–8.19 (m, 1H), 
7.57–7.53 (m, 1H), 7.47 (ddd, J = 1.2, 6.9 and 8.2, 1H), 7.36 – 7.32 (m, 1H), 7.20 (t, J = 7.6, 
2H), 7.10–7.06 (m, 3H), 6.98–6.95 (m, 3H), 6.32–6.30 (m, 2H), 4.66 (s, 2H), 2.29 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 143.7, 138.6, 137.0, 133.9, 133.8, 131.6, 130.1, 129.7, 128.2, 
128.0, 127.9, 127.4, 126.7, 126.0, 125.1, 125.0, 124.9, 123.0, 100.6, 100.5, 47.7, 13.0. IR 
(KBr, ) 3445, 3076, 3026, 2936, 2865, 1972, 1835 cm–1. MS (m/z, rel. int., %) 473 (M+, 
100), 346 (4), 268 (19), 254 (52), 91 (59), 65 (6). Anal. Calcd. for C26H20IN C, 65.97; H, 
4.26; N, 2.96. Found C, 66.20; H, 4.31; N, 2.91. 
 
Ethyl 3-benzyl-2-methyl-4-phenyl-3H-benzo[e]indole-1-carboxylate (1’a). Yellow 
solid. Mp. 132–133ºC. Yield: 41%. 1H NMR (400 MHz, CDCl3) δ 8.91–8.89 (m, 1H), 7.82–
7.79 (m, 1H), 7.54 (ddd, J= 1.4, 6.8 and 8.4, 1H), 7.43 (ddd, J = 1.2, 6.8 and 8.0, 1H), 7.35, 
(s, 1H), 7.31–7.27 (m, 1H), 7.19–7.15 (m, 2H), 7.12–7.06 (m, 5H), 6.39–6.37 (m, 2H), 4.97 
(s, 2H), 4.53 (q, J = 7.1, 2H),2.52 (s, 3H), 1.47 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) 
δ 167.5, 141.1, 139.8, 137.2, 131.2, 129.6, 129.4, 128.3, 128.2, 127.7, 127.6, 127.3, 127.0, 
126.9, 126.5, 125.4, 125.1, 125.0, 124.1, 121.4, 109.1, 60.4, 48.2, 14.4, 12.0. IR (KBr, ) 
3378, 3058, 3025, 2980, 2850, 1958, 1799, 1690 cm
–1
. MS (m/z, rel. int., %) 563 (M
+
, 100), 
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436 (1), 363 (8), 345 (17), 272 (13), 91 (82). Anal. Calcd. for C29H25NO2 C, 83.03; H, 6.01; 
N, 3.34. Found C, 82.98; H, 5.78; N, 3.27. 
 
Example of functionalization of an iodocyclized product  
Ethyl 11-benzyl-12-methyl-5,6-diphenyl-11H-benzo[e]naphtho[2,1-g]indole-13-
carboxylate (6a).
[16]
 Diphenylacetylene (89mg,0.5mmol), Pd(OAc)2 (5 mg, 5mol%), NaOAc 
(41 mg, 0.5 mmol) and LiCl (10 mg, 0.25 mmol) were successively added to a stirred solu-
tion of 1a (139 mg, 0.25 mmol) in DMF (1 mL). The system was heated at 100ºC for 24 h. 
After the reaction was completed, the system was cooled to room temperature and the prod-
ucts were extracted with EtOAc (3 × 10 mL), the organic phase was washed with water and 
brine. The extract was dried over MgSO4, filtered and concentrated under reduced pressure. 
The residue was purified via column chromatography on silica gel, eluting with hexane. The 
product (145 mg, 98%) was obtained as a yellow solid. Mp. 236–236.5ºC. 1H NMR (400 
MHz, CDCl3) δ 8.73 – 8.71 (m, 1H), 8.35–8.33 (m, 1H), 7.69–7.64 (m, 3H), 7.47–7.38 (m, 
3H), 7.35–7.31 (m, 2H), 7.22–7.17 (m, 2H), 7.07–7.06 (m, 4H), 7.01–6.90 (m, 5H), 6.27 (d, 
J = 7.2, 2H), 5.71 (d, J = 15.6, 1H), 5.36 (d, J = 15.6, 1H), 4.54–4.51 (m, 2H), 2.67 (s, 3H), 
1.48 (t, J = 7.1, 3H). 
13
C NMR (100 MHz, CDCl3) δ 167.3, 143.6, 143.1, 139.5, 137.4, 136.4, 
136.0, 132.5, 131.8, 131.5, 130.8, 130.5, 129.6, 128.8, 128.3, 128.1, 128.0, 127.5, 127.3, 
126.9, 126.8, 126.6, 126.3, 126.1, 126.0, 125.9, 125.5, 125.0, 124.7, 123.1, 121.8, 121.5, 
111.9, 60.5, 51.6, 14.4, 13.1. MS (m/z, rel. int., %) 595 (M
+
, 17), 458 (10), 419 (23), 254 
(14), 149 (13), 105 (100), 91 (84), 77 (45). HRMS (ESI, m/z) calcd. for C43H33NO2([M+H]
+
): 
596.2590; Found: 596.2583. 
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